Coherus Oncology, Inc.
CHRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35,531 | $297,767 | -$56,569 | -$50,696 |
| Dep. & Amort. | $966 | $1,016 | $1,046 | $5,192 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,389 | $5,421 | $5,372 | $6,384 |
| Change in WC | -$9,389 | -$23,652 | $10,859 | $48,196 |
| Other Non-Cash | -$5,774 | -$327,184 | $13,466 | $19,532 |
| Operating Cash Flow | -$46,339 | -$46,632 | -$25,826 | $28,608 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$68,850 | -$20,726 | $0 | $0 |
| Inv. Sales/Matur. | $1,650 | $0 | $0 | $0 |
| Other Inv. Act. | -$27 | $483,364 | -$17,486 | -$542 |
| Investing Cash Flow | -$67,227 | $462,638 | -$17,486 | -$542 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$233,185 | $0 | $0 |
| Stock Issued | $0 | $188 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$264 | -$10 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | -$48,527 | $0 | $241 |
| Financing Cash Flow | $2 | -$281,524 | -$264 | $231 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$113,564 | $134,482 | -$43,576 | $28,297 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $217,156 | $82,674 | $126,250 | $97,953 |
| End Cash | $103,592 | $217,156 | $82,674 | $126,250 |
| Free Cash Flow | -$46,339 | -$46,632 | -$25,826 | $28,608 |